Cardiac services at MUSC Children’s continue to expand and grow with the recent return of two MUSC former physicians. 

John Rhodes, M.D.
Dr. John Rhodes

Dr. John Rhodes, a pediatric and adult congenital invasive cardiologist, will serve as operations director for the Congenital Heart Center and as an invasive/interventional specialist for children and adults with congenital heart disease. Dr. Rhodes completed his residency in pediatrics at MUSC, and we are very happy about his return.

Prior to joining MUSC, Dr. Rhodes worked from 2003 to 2013 at Duke University Medical Center as chief of the Duke Children’s Heart Center, director of the Pediatric & Adult Congenital Interventional Cardiac Catheterization Laboratory, and co-director of the Adult Congenital Heart Program. More recently, Dr. Rhodes worked from 2013-2017 at Nicklaus Children’s Health System in Miami as director of cardiology, director of adult congenital and director of the Interventional Cardiac Catheterization Laboratory.

He has great enthusiasm about the new Shawn Jenkins Children’s Hospital and says the future hospital and the opportunity to return to the academic and research settings were contributing factors to his return.

Dr. Rhodes clinical interests involve diagnostic and interventional catheterization procedures for children and adults with complex congenital heart disease. He has helped pioneer several techniques, including transcatheter atrial septal defect (ASD) closure with the CARDIOFORM Gore Helex™ Septal Occluder device, intracardiac echocardiographic imaging to guide catheter interventions, cutting balloon angioplasty of stenotic branch pulmonary arteries, and pulmonary vein stent angioplasty for pulmonary vein stenosis following radiofrequency ablation of atrial fibrillation.

He also served as the national principal investigator for the REDUCE trial for the management of patients for stroke-related patent foramen ovale device closure and is an investigator for trial including the Edwards Lifesciences transcatheter Sapien pulmonary stent valve, the MELODY pulmonary stent valve post approval study, the new CARDIOFORM Gore ASD Occluder device, and bare metal as well as covered stent angioplasty for coarctation of the aorta.

Dr. Heather Henderson
Dr. Heather Henderson

There is equal excitement about Dr. Heather Henderson’s return and her new role.  Dr. Henderson earned her medical degree from MUSC, and we are fortunate for her return. She is a board-certified pediatric cardiologist with expertise in pediatric cardiomyopathy, heart failure, and heart transplantation. Dr. Henderson will co-manage the heart failure/heart transplant program. She works part of the time in general cardiology but also works with transplant patients, those children who are waiting for a transplant and those who have had one, both in the patient’s home and at the hospital.

She graduated from the College of Charleston before earning her medical degree. She completed her pediatric internship and residency at the University of Alabama Birmingham, followed by a pediatric cardiology fellowship at Emory University and Children’s Healthcare of Atlanta. Dr. Henderson completed an additional year of advanced training in pediatric heart failure and transplantation at Emory University. Her clinical interests include pediatric cardiomyopathies, especially those related to chemotherapy and neuromuscular disorders. She specializes in heart failure management from cardiomyopathy and congenital heart disease, including the use of mechanical circulatory support and ventricular assist devices when necessary, as well as the care of heart transplant recipients.

Asked about the new children’s hospital, she said, “I am ecstatic.” She looks forward to cardiology being located on one floor in the new hospital, eliminating the need for staff and patients to move between floors, which she knows will result in benefits for patients.